Picton Mahoney Asset Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$672 Hold
48
﹤0.01% 1217
2025
Q4
$539 Hold
48
﹤0.01% 1187
2025
Q3
$1K Hold
48
﹤0.01% 869
2025
Q2
$1K Hold
48
﹤0.01% 744
2025
Q1
$1K Hold
48
﹤0.01% 716
2024
Q4
$1K Hold
48
﹤0.01% 615
2024
Q3
$1K Buy
+48
New +$1.1K ﹤0.01% 607
2015
Q2
Sell
-7,300
Closed -$359K 296
2015
Q1
$359K Sell
7,300
-4,800
-40% -$222K 0.01% 187
2014
Q4
$550K Buy
+12,100
New +$475K 0.03% 184

Other funds holding AVNS

Picton Mahoney Asset Management's AVNS Position: Q1 2026 in Review

Picton Mahoney Asset Management held its Avanos Medical (AVNS) position steady in Q1 2026 at 48 shares worth $672. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

Picton Mahoney Asset Management first reported a position in AVNS in Q4 2014 and has held it in 9 quarters since. The position peaked at $550K in Q4 2014. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Picton Mahoney Asset Management held 48 shares of Avanos Medical worth $672 as of Q1 2026.
  • Picton Mahoney Asset Management left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #1217 holding.
  • Picton Mahoney Asset Management first reported a position in Avanos Medical in Q4 2014 and has held it in 9 quarters since.
  • Picton Mahoney Asset Management's Avanos Medical position peaked at $550K in Q4 2014.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.